Pancreatic Cancer Treatment Market Size, Industry Analysis Report, Regional Outlook, Application Development Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI1941
Pancreatic Cancer Treatment Market size is projected to experience significant growth from 2017 to 2024.
Pancreatic cancer treatment market size should witness significant growth due to increasing healthcare expenditure, technological advancements and drug innovations coupled with huge number of unmet needs associated with the disease. Increased tobacco consumption, smoking, obesity and rising awareness levels regarding various treatment options should further drive the business size. Incidence rates of disease is mostly observed in the age group of 65 to 75 years. Therefore, rising geriatric population base are more prone to such disorder.
The National Pancreatic Cancer Foundation provide support for patients and families fighting against the disease. The National Comprehensive Cancer Network (NCCN), is a non-profile alliance of leading 27 cancer centers globally. The alliance provides books for patients on esophageal, lung, stomach and various other cancer types. Increased government initiatives to support and spread disease awareness should boost the therapy demand. High cost associated with the disease treatment, adverse side effects, and difficulty in diagnosis at initial stage are some of the factors restraining industry growth.
Pancreatic cancer is divided into two major types known as exocrine and endocrine tumors. About 95% of cases are exocrine. Its most common type is pancreatic ductal adenocarcinoma. The endocrine type is less prevalent, and still looking for effective treatment options. Hospitals should contribute for major revenue share over the forecast period. Increased disease treatment procedures in hospitals and growing number of patient visit should drive the segment growth.
Targeted therapy should contribute for significant revenue share over the forecast period. The growth is attributed to the development of innovative biologic therapies and targeted drugs in order to decrease the adverse effects of the ongoing therapy, such as chemotherapy. Targeted therapy attacks specific pathway or proteins involved in the growth of tumor cells. Researchers are working to develop novel targeted therapies which will drive pancreatic cancer treatment market growth over the forecast period.
In 2015, as per the National Center for Biotechnology Information, pancreatic cancer is one of the most severe malignancies and it is considered as the most common cause of cancer deaths in the U.S. The American Pancreatic Association (APA) is the association for doctors and researchers involved in exocrine pancreas disease. The aim of the association is to foster clinical and basic science research for the treatment of diseases. These factors should drive U.S. pancreatic cancer treatment market growth during the forecast timeframe.
In July 2015, Australasian Gastro?Intestinal Trials Group (AGITG) had organized Pancreatic Cancer Surgical Guidelines Workshop in collaboration with Avner Pancreatic Cancer Foundation. The Australian Pancreatic Cancer Genome Initiative (APGI) is the worldwide research initiative of more than 100 scientists, allied health professionals and clinicians engaged in research and care. Such associations should drive industry growth over the forecast period.
Some of the industry players are Eli Lilly and Company, Celgene, F. Hoffmann-La Roche, Novartis, Clovis Oncology, Amgen, Merck, Teva Pharmaceutical Industries, Pfizer and PharmaCyte Biotech. Partnerships, mergers and collaborations with established industry players are the major strategies adopted by the companies to gain revenue share.
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.